+29.1%
MRNA vs RRC
+31.5%
-2.3%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | RRC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +0.3% | +0.4% | +0.6% |
| 7D | -8.2% | -1.2% | -7.1% | -7.9% |
| 30D | +125.6% | +3.0% | +122.6% | +123.7% |
| 3M | +197.1% | +7.3% | +189.8% | +190.6% |
| 6M | +148.5% | +3.6% | +144.9% | +143.7% |
| YTD | +363.3% | +19.4% | +343.9% | +336.6% |
| 1Y | +462.0% | +21.4% | +440.6% | +425.9% |
| All | +29.1% | +31.5% | -2.3% | +12.9% |
Cumulative growth
Daily Returns
Daily percentage return beside RRC.
Daily Out/Under-Performance
Portfolio return minus RRC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RRC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded RRC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling